HomeNewscoronavirusCOVID-19 Vaccination | Second jabs race past first ones for first time in May

COVID-19 Vaccination | Second jabs race past first ones for first time in May

Government data analysed by News18 shows that out of 16.8 million jabs given so far in May across the country, nearly 8.9 million were second doses while the first doses were lower at 7.9 million.

May 11, 2021 / 16:11 IST
Story continues below Advertisement
The Union Health Secretary in a review meeting on May 11 told states to ensure all beneficiaries who have taken the first dose are prioritised for the second doses.
The Union Health Secretary in a review meeting on May 11 told states to ensure all beneficiaries who have taken the first dose are prioritised for the second doses.

For the first time since vaccination began in January, more second doses of the jabs have been given to people than the first dose this month, showing that both the Centre and the state governments are now focusing on first completing the vaccination protection for the people of the priority groups.

Government data analysed by News18 shows that out of 16.8 million jabs given so far in May across the country, nearly 8.9 million were second doses while the first doses were lower at 7.9 million. Out of the 7.9 million first doses, 2.5 million doses were given to the 18-44 age group for whom vaccination began on May 1, leaving just 5.4 million people who got the first dose in the age group of 45+ or the health and frontline workers. “This shows that out of total people of priority group of 45+ coming for vaccination in May, nearly 63 percent came for their second jabs. This is a good development as we will have a bigger number of fully protected people. It is a fact that 80 percent of all mortalities due to the COVID are among the 45+ age group even as of today,” a senior government official explained.

Story continues below Advertisement

The official said that Centre in May asked states to devote 70 percent of vaccines being provided to the states for the 45+ age group, exclusively for second doses. In April, 75% of the doses given across India were first ones against 47% so far in May and Centre expects the second dose ratio to grow further now on.

The Union Health Secretary in a review meeting on May 11 told states to ensure all beneficiaries who have taken the first dose are prioritised for the second doses. “The urgent need to address large number of beneficiaries waiting for 2nd dose was stressed. In this regard, States can reserve at least 70% of the Vaccines supplied to them from Government of India channel (free of cost) for second dose vaccination and remaining 30% for first dose. This however is indicative. States have the liberty to enhance this to as much as 100%. The States were asked to undertake awareness campaign for reinforcing importance of complete vaccination with two doses of the vaccine,” the government said in a statement.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show